These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29393172)

  • 41. Predicting conversion of patients with Mild Cognitive Impairment to Alzheimer's disease using bedside cognitive assessments.
    Clarke A; Ashe C; Jenkinson J; Rowe O; A D N I ; Hyland P; Commins S
    J Clin Exp Neuropsychol; 2022 Dec; 44(10):703-712. PubMed ID: 36803664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Self-Regulation of Driving Behaviors in Persons With Early-Stage Alzheimer's Disease.
    Davis R; Owens M
    J Gerontol Nurs; 2021 Jan; 47(1):21-27. PubMed ID: 33377981
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
    Futschek IE; Schernhammer E; Haslacher H; Stögmann E; Lehrner J
    Exp Gerontol; 2023 Feb; 172():112045. PubMed ID: 36509298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multi-domain Cognitive Testing: A Biomarker for Classifying the Cognitive Status of Mild Cognitive Impairment and Alzheimer's Disease.
    Kumar Gurja JP; Muthukrishnan SP; Tripathi M; Mehta N; Sharma R
    Neurol India; 2022; 70(3):1057-1063. PubMed ID: 35864639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer's disease.
    Jiang X; Howard JH; Rebeck GW; Turner RS
    PLoS One; 2021; 16(6):e0252958. PubMed ID: 34125847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A simple counting of verbal fluency errors discriminates between normal cognition, mild cognitive impairment and Alzheimer's disease.
    Wajman JR; Cecchini MA
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2023 May; 30(3):370-387. PubMed ID: 35174776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance.
    Bosch B; Arenaza-Urquijo EM; Rami L; Sala-Llonch R; Junqué C; Solé-Padullés C; Peña-Gómez C; Bargalló N; Molinuevo JL; Bartrés-Faz D
    Neurobiol Aging; 2012 Jan; 33(1):61-74. PubMed ID: 20371138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Motivational processes in mild cognitive impairment and Alzheimer's disease: results from the Motivational Reserve in Alzheimer's (MoReA) study.
    Forstmeier S; Maercker A
    BMC Psychiatry; 2015 Nov; 15():293. PubMed ID: 26578083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of Apolipoprotein E4 on the Driving Behavior of Patients with Amnestic Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia.
    Stanitsa E; Economou A; Beratis I; Kontaxopoulou D; Fragkiadaki S; Papastefanopoulou V; Pavlou D; Papantoniou P; Kroupis C; Papatriantafyllou J; Stefanis L; Yannis G; Papageorgiou SG
    J Alzheimers Dis; 2021; 84(3):1005-1014. PubMed ID: 34602476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical validity of the Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB) in Mild Cognitive Impairment and Alzheimer's Disease.
    Conca F; Esposito V; Catricalà E; Manenti R; L'Abbate F; Quaranta D; Giuffrè GM; Rossetto F; Solca F; Orso B; Inguscio E; Crepaldi V; De Matteis M; Rotondo E; Manera M; Caruso G; Catania V; Canu E; Rundo F; Cotta Ramusino M; Filippi M; Fundarò C; Piras F; Arighi A; Tiraboschi P; Stanzani Maserati M; Pardini M; Poletti B; Silani V; Marra C; Di Tella S; Cotelli M; Lodi R; Tagliavini F; Cappa SF
    Alzheimers Res Ther; 2024 May; 16(1):98. PubMed ID: 38704608
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.
    Morris JC
    Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.
    Scaricamazza E; Colonna I; Sancesario GM; Assogna F; Orfei MD; Franchini F; Sancesario G; Mercuri NB; Liguori C
    Neurol Sci; 2019 Jul; 40(7):1377-1382. PubMed ID: 30903419
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cognitive Decline in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease: A Prospective Cohort Study.
    Hamilton CA; Matthews FE; Donaghy PC; Taylor JP; O'Brien JT; Barnett N; Olsen K; Lloyd J; Petrides G; McKeith IG; Thomas AJ
    Am J Geriatr Psychiatry; 2021 Mar; 29(3):272-284. PubMed ID: 32863138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions.
    Lee GJ; Lu PH; Hua X; Lee S; Wu S; Nguyen K; Teng E; Leow AD; Jack CR; Toga AW; Weiner MW; Bartzokis G; Thompson PM;
    Biol Psychiatry; 2012 May; 71(9):814-21. PubMed ID: 22322105
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Comparison of Serial Position Effects in Patients with Mild Cognitive Impairment due to Parkinson's Disease or to Alzheimer's Disease.
    Meyer A; Handabaka I; Ehrensperger MM; Gschwandtner U; Hatz F; Monsch AU; Stieglitz RD; Fuhr P
    Dement Geriatr Cogn Disord; 2020; 49(2):170-178. PubMed ID: 32634809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammation in mild cognitive impairment due to Parkinson's disease, Lewy body disease, and Alzheimer's disease.
    King E; O'Brien J; Donaghy P; Williams-Gray CH; Lawson RA; Morris CM; Barnett N; Olsen K; Martin-Ruiz C; Burn D; Yarnall AJ; Taylor JP; Duncan G; Khoo TK; Thomas A
    Int J Geriatr Psychiatry; 2019 Aug; 34(8):1244-1250. PubMed ID: 30993722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuropsychological Impairments and Their Cognitive Architecture in Mild Cognitive Impairment (MCI) with Lewy Bodies and MCI-Alzheimer's Disease.
    Ciafone J; Thomas A; Durcan R; Donaghy PC; Hamilton CA; Lawley S; Roberts G; Colloby S; Firbank MJ; Allan L; Petrides G; Taylor JP; O'Brien JT; Gallagher P
    J Int Neuropsychol Soc; 2022 Oct; 28(9):963-973. PubMed ID: 34666864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Test Your Memory for Mild Cognitive Impairment (TYM-MCI).
    Brown JM; Lansdall CJ; Wiggins J; Dawson KE; Hunter K; Rowe JB; Parker RA
    J Neurol Neurosurg Psychiatry; 2017 Dec; 88(12):1045-1051. PubMed ID: 28912299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.